Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse
- 12 February 2004
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 35 (1), 93-105
- https://doi.org/10.1016/j.jpba.2003.12.019
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Metabonomics: a platform for studying drug toxicity and gene functionNature Reviews Drug Discovery, 2002
- Expression Profiling of Acetaminophen Liver Toxicity in Mice Using Microarray TechnologyBiochemical and Biophysical Research Communications, 2001
- Free radical–induced megamitochondria formation and apoptosisFree Radical Biology & Medicine, 1999
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999
- High density synthetic oligonucleotide arraysNature Genetics, 1999
- Expression monitoring by hybridization to high-density oligonucleotide arraysNature Biotechnology, 1996
- Characterization and tissue-specific expression of the human ‘very low density lipoprotein (VLDL) receptor’ mRNAHuman Molecular Genetics, 1994
- N-acetyl-p-benzoquinone imine-induced changes in the energy metabolism in hepatocytesChemico-Biological Interactions, 1990
- Metabolic profiling of body fluids by proton NMR: Self‐poisoning episodes with paracetamol (acetaminophen)Magnetic Resonance in Medicine, 1988
- Acetaminophen-induced Hepatic NecrosisPharmacology, 1974